Skip to main content

Peer Review reports

From: Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases

Original Submission
12 Oct 2020 Submitted Original manuscript
15 Nov 2020 Author responded Author comments - Matthew Mills
Resubmission - Version 2
15 Nov 2020 Submitted Manuscript version 2
23 Dec 2020 Reviewed Reviewer Report
10 Jan 2021 Author responded Author comments - Matthew Mills
Resubmission - Version 3
10 Jan 2021 Submitted Manuscript version 3
12 Feb 2021 Author responded Author comments - Matthew Mills
Resubmission - Version 4
12 Feb 2021 Submitted Manuscript version 4
18 Feb 2021 Author responded Author comments - Matthew Mills
Resubmission - Version 5
18 Feb 2021 Submitted Manuscript version 5
22 Feb 2021 Author responded Author comments - Matthew Mills
Resubmission - Version 6
22 Feb 2021 Submitted Manuscript version 6
Publishing
24 Feb 2021 Editorially accepted
4 Mar 2021 Article published 10.1186/s12885-021-07971-w

You can find further information about peer review here.

Back to article page